ClinicalTrials.Veeva

Menu

Cabergoline As An Adjuvant To Clomiphene Citrate For Management Of Unexplained Infertility

A

Assiut University

Status and phase

Unknown
Phase 3
Phase 2

Conditions

Infertility

Treatments

Drug: Cabergoline Oral Tablet
Drug: Placebo Oral Tablet
Drug: Clomiphene Citrate 50mg

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Infertility refers to an inability to conceive after having regular unprotected sex. Infertility can also refer to the biological inability of an individual to contribute to conception, or to a female who cannot carry a pregnancy to full term. In many countries infertility refers to a couple that has failed to conceive after 12 months of regular sexual intercourse

Enrollment

120 estimated patients

Sex

Female

Ages

20 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • unexplained infertility, Primary or secondary.
  • Absence of galactorrhoea.
  • Normal serum prolactin.
  • Normal hysterosalpingography.
  • Normal spermogram.

Exclusion criteria

  • Women on other line of treatment as aromatase inhibitors,gonadotrophins, or tamoxifen.
  • Known hypersensitivity for cabergoline or clomiphene citrate.
  • Other factors of infertility as tubal factor, uterine factor or male factor.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

120 participants in 2 patient groups

study group
Experimental group
Description:
will receive a dose of Clomiphene citrate 50 mg tablet , 1 tab twice daily for 5 days from the third day of menses to the seven day and cabergoline 0.25 mg (half tablet) every 3 days (one package) first three months then Clomiphene citrate 50 mg tablet , 2 tabs twice daily for 5 days from the third day of menses to the seven day and cabergoline 0.25 mg (half tablet) every 3 days (one package)
Treatment:
Drug: Clomiphene Citrate 50mg
Drug: Cabergoline Oral Tablet
control group
Active Comparator group
Description:
will receive a dose of Clomiphene citrate and placebo tablets with same dose and duration
Treatment:
Drug: Clomiphene Citrate 50mg
Drug: Placebo Oral Tablet

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems